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Abstract 
Background: Gene therapy is one of the treatment method for diabetes mellitus. An insulin gene, under control 
of heat shock inducer promoter was used in the study. 
Materials and Methods: Six mice used in this study. Streptozotocin (STZ) induced diabetes mellitus in 
BALB/C mice and rats. Recombinant plasmid was injected to each animal. Animal’s blood sugar (BS) was 
measured. Warming was done at injection site with a hair dryer to induced gene expression. 
Results: Immediately after warming blood sugar was increased in mouse 1 and decreased after one hour. 
However, blood sugar increased again in mice 2 and 4. Blood sugar increased for two hours after warming in 
mouse 3. Blood sugar increased to 150 mg/dl after STZ injection and immediately after warming reached to 
160 mg/dl, after one hour BS dropped to 116 mg/dl and on the second hour was 126 mg/dl, in mouse 5 BS 
had an increasing trend, BS in mouse 6 had a similar pattern to mouse 2. 
Conclusion: With fixing the defects of the project will be used in gene therapy in future.  
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Introduction 
Diabetes mellitus is a metabolic disorder with 
chronic hyperglycemia because of incomplete insulin 
secretion. Based on WHO reports on April 2016, 
diabetic people death rate will reach to 1.5 million in 
20201.  
Some patients using insulin regiment should 
performed self monitoring of blood glucose prior to 
eating or diving2. Other method is Pancras 
transplantation for treating type 1 diabetes2, but Van 
Dellen proposed that probably 22% reject Pancras 
transplantation3. Basta et al. proposed that appropriate 
donors are scarce and Pancras islands transplantation 
is laborious. In addition, there is side effects of 
immunosuppressive drugs used as avoid rejection of 
transplant4. Insulin gene therapy is another treatment 
for type 1 diabetes5. Thule et al used DNA responsive 
to liver promoter (contained inhibitory insulin 
response sequence) prepared a liver-targeted insulin 
transgene and transferred to streptozotocin diabetic 
mice by recombinant adenovirus vector. In that study, 
mice in compare to those received empty vector 
showed normal blood glucose level6.  
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Ruihuan Chen et al. proposed a theory that increase 
liver insulin expression in presence to glucose and 
reduction of glucose in presence to insulin can 
achieve to treating type 1 diabetes. Expression of 
glucose 6 phosphatase in liver stimulate by glucose 
and inhibit by insulin. The glucose 6 phosphatase 
promoter in assistance by intronic enhancer of 
aldolase B gene can be regulated insulin expression 
in diabetic mouse effectively7. 
Hyun Chul Lee et al. used recombinant adeno-
associated virus controlled by hepatocyte-specific L-
type pyruvate kinase (LPK) promoter to expression 
of single-chain insulin analogue (SIA). The 
recombinant adeno-associated virus could regulate 
expression of SIA in presence to blood glucose. The 
expressed SIA can improve autoimmune and STZ- 
diabetic mouse as long-term period8. 
Methods 
Insulin gene: We used insulin gene controlled by 
heat shock protein 70 (HSP70) promoter constructed 
previously by our team. It consists of a destination 
vector named pJTI Fast Dest prepared via gateway 
system9. The construct reduces immune reaction in 
host cells. The promoter induced by heat and 
transcription initiate. Although it may not be possible 
for humans to function for many years, it decided to 
determine the effect of this structure on the animal's 
body. It should be noted that in historical sources, the 
structural issue with non-viral profile and the 
induction of its promoter with heat was not found. 
This is the first experiment with this construct on a 
laboratory animal. 
Laboratory animal: Shahid Beheshti University of 
Medical Sciences ethical committee confirmed the 
ethical status of animal under experimental test. We 
used STZ- Balb/c mice and rats for test the construct 
(Table 1). Mice were diabetic by intra peritoneal 
injection and rats by subcutaneous injection of STZ. 
The mail Balb/c mice were received 100mg/kg STZ 
for 2 weeks. Rats were received 40mg/kg STZ. 
Preparations of therapeutic gene construct: 
Recombinant plasmid (contained insulin gene and 
heat induced promoter) was transformed into E. coli 
TOP10 strain. Bacterial colony contain recombinant 
plasmid were cultured and plasmid extraction was 
done by alkaline method. Recombinant plasmid was 
confirmed by gel electrophoresis in compare to empty 
plasmid. Each mouse received 100-microgram plasmid 
via intra peritoneal injection and each rat was received 
100-microgram plasmid through intra muscular 
injection. 
Animal grouping: In this research, three rats and six 
Balb/c mice were used and two mice as non-diabetic 
control were considered. Blood sugar was measured 
by electronic glucometer (ACCU-CHEK) before 
injection of STZ. Blood glucose were measured 
through tail vein. 
Ethics Committee of Iran National Science Foundation 
(grant No. 91057380) has approved the protocol for this 
research project. 
Results 
After animal injection by therapeutic gene, local 
injection site was heated by hair dryer for 10 minutes 
at 42oC, but maybe there was some irregularity in this 
process (heating). Blood glucose was checked by 
glucometer and recorded as table 1. Two rats did not 
recovery and removed from test system. 
Table 1 shows blood glucose of first mouse that 
increased immediately after warming, decreased after 
one hour, and increased again. Blood glucose of 
second and fourth mice increased after two hours and 
not affected by construct (or therapeutic gene not 
entrance in host cell and removed from system). Only 
blood glucose of third mouse increased to 150 mg/dl 
after injection of STZ and immediately increased to 
160 mg/dl then decreased so that after 1-hour reach to 
116 mg/dl and after 2 hours reach to 126 mg/dl. Blood 
glucose of fifth mouse after STZ injection increased 
because did not receive therapeutic gene. Blood 
glucose of sixth mouse like second mouse increased 
then decreased again. After heating the blood glucose 
of third rat increased highly so that glucometer could 
not record it, but two hours after promoter induction 
reached to 518 mg/dl, which show the effect of 
construct. 
Discussion 
Gene therapy is a process that transfers genetic 
materials into animal cells to improve a destructed 
gene function. In this study, we used heat inducing 
insulin construct. The construct was destination vector 
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contained insulin gene and heat shock protein 70 
promoter constructed in our previous paper, the 
construct induced by heat at 42˚C and secreted 
insulin9. It was expected that when injected via IP or 
IM into animals could enter into the host cells and 
induced insulin at 42°C. Resulted were different with 
different animals, it is possible that therapeutic gene 
was entered in host cells in some animals but could not 
be entered into cells of another animal and gene lead 
to destruct.  
 
 
Figure 1. Graph shows results of STZ injection to laboratory animals and heated at injection location by hair dryer. 














































































Mouse number 1 118 171 211 173 180 
Mouse number 2 90 136 169 147 150 
Mouse number 3 81 150 160 116 126 
Mouse number 4 86 99 124 196 157 
Mouse number 5 (control) 88 108 121 139 110 
Mouse number 6 (control) 84 125 129 131 114 
Rat number 1 - 337 - - - 
Rat number 2 - 378 - - - 
Rat number 3 - 374 Hi Hi 518 
 
 
Ramezani et al.                                            The Study on Possible Gene Therapy on Diabetics Type I Using Insulin Gene … 
NBM                                                                            48                                   Novelty in Biomedicine 2019, 2, 45-8 
Using viruses for gene transfer is a problem because 
stimulate host immune system and produce antiviral 
antibody. To reduction of antiviral antibody, He-CX 
et al. used direct injection of naked DNA, they 
proposed that it is the immune process but with 
reduced efficacy for gene therapy in animals5. We 
used plasmid DNA for reducing the risk of antibody 
secretion. The plasmid was a eukaryotic destination 
vector named pJTI Fast Dest prepared via Gateway 
system9. 
It is emphasized that stress and environmental 
condition might effect on animal and lead to increase 
blood glucose and promoter induction could not 
decrease blood glucose. Figure 1 showed that 
animals’ blood glucose was different at different 
times but immediately after heating (1st, 2nd, 3rd 
animals) or after one hour (4th animal) blood glucose 
increased and then decreased. Some trouble of this 
method including: construct did not enter in the host 
cells, destruction of construct before cell entrance, 
inappropriate heating, effect of stress on animal 
condition, inappropriate destination vector for 
integration of the therapeutic gene into the host 
chromosome, or low time for blood glucose 
regulation. 
Conclusion 
Results indicated that could be assured for the 
efficacy of therapeutic gene in future if fix problems. 
This is the first experiment with this construct is 
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